Affiliation:
1. MVZ CytoMol Frankfurt Germany
2. Hologic Deutschland GmbH Wiesbaden Germany
3. Universitätsfrauenklinik Frankfurt Frankfurt Germany
4. Department of Mathematics, Natural and Economic Sciences Ulm University of Applied Sciences Ulm Germany
5. BioTeSys GmbH Esslingen Germany
Abstract
AbstractBackgroundDigital cytology (DC) with artificial intelligence (AI) is a new approach. The authors compared DC with liquid‐based cytology (LBC) using computer assistance (CAS) in a retrospective, noninterventional study.MethodsIn total, 1994 ThinPrep LBC slides (Hologic), which were previously analyzed in 2020 using an imaging system with CAS in routine cotesting for cytology/human papillomavirus, were reviewed in a blinded mode using the Genius Digital Diagnostics System (Hologic). In 555 cases, a histology result was available. The slides were digitally scanned (volumetric scan) at 14 levels integrated into one. AI algorithms were used to present a gallery of six tiles each (containing objects of interest) in five categories. Six additional tile rows were available, from which the diagnoses were made. All cases with a mismatch between DC and imaging system results were reviewed by an additional cytopathologist.ResultsIn 86.56% of cases, a complete match between both systems was observed using the same cytology categories. When also considering the histology results, the match was 90.37%. In addition, when a cytology follow‐up and/or a retrospective review was applied, the match reached 97.34%. In only 0.65% of cases was a major discrepancy observed (two grades of cytology or a low‐grade squamous intraepithelial lesion/high‐grade squamous intraepithelial lesion [LSIL/HSIL] shift), and none were identified by DC. Significantly more cases of higher severity (atypical squamous cells cannot exclude high grade [ASC‐H], high‐grade squamous intraepithelial lesion [HSIL]) were identified with DC, and its negative predictive value was higher. The screening time was significantly shorter with DC.ConclusionsWith the Genius system for DC, the sensitivity for HSIL+/ASC‐H and the specificity for LSIL and HSIL were superior to LBC and CAS. Screening time was significantly lower.
Reference17 articles.
1. World Health Organization (WHO).Human Papillomavirus (HPV) and Cervical Cancer. WHO; 2022. Accessed March 21 2023.https://www.who.int/news‐room/fact‐sheets/detail/cervical‐cancer
2. Carcinogenic human papillomavirus infection
3. Gemeinsamer Bundesausschuss.Tragende Gründe zum Beschluss des Gemeinsamen Bundesaus‐schusses über eine Änderung der Krebsfrüherkennungs‐Richtlinie und eine Änderung der Richtlinie für organisierte Krebsfrüherkennungsprogramme: Programm zur Früherkennung von Zervixkarzinomen;2018. Gemeinsamer Bundesausschuss; 2020. Accessed March 21 2023.https://www.g‐ba.de/downloads/40‐268‐5486/2018‐11‐22_oKFE‐RL_Zervixkarzinom_TrG.pdf
4. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献